Bioanalytical Laboratory Considerations In Immuno-Oncology Drug Development

Listen to the Podcast

Listen to Dr. Mike Brown’s, Senior Director of Immunoanalytical and Bioanalytical Services, podcast to learn about bioanalytical laboratory considerations in immuno-oncology drug development, such as the importance of pharmacokinetic and immunogenicity assays, as well as the importance of early FDA engagement.

To learn more about our integrated immuno-oncology solutions, contact us today.
Bioanalytical & ADME Laboratory Services

Accelerate and enhance your discovery, preclinical and clinical programs

Validated bioanalytical methods list

LC/MS/MS Methods, Immunoassay Biomarker Methods and LC/MS Biomarker Methods

Bioanalytical Immunoassay Services to Accelerate Biosimilar Development

Providing the tools and experience to support biosimilar studies

Assay Development for Large-Scale Clinical Studies

Bioanalytical expertise to support large-scale, international studies

Read More